Fortitude Family Office’s Chemed CHE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$1.51K Sell
4
-19
-83% -$8.14K ﹤0.01% 1378
2025
Q4
$9.84K Buy
23
+21
+1,050% +$9.14K ﹤0.01% 586
2025
Q3
$895 Sell
2
-4
-67% -$1.81K ﹤0.01% 1591
2025
Q2
$2.92K Buy
6
+3
+100% +$1.71K ﹤0.01% 1021
2025
Q1
$1.85K Sell
3
-4
-57% -$2.27K ﹤0.01% 933
2024
Q4
$3.71K Hold
7
﹤0.01% 914
2024
Q3
$4.21K Buy
+7
New +$3.97K ﹤0.01% 835

Other funds holding CHE

Fortitude Family Office's CHE Position: Q1 2026 in Review

Fortitude Family Office reduced its Chemed (CHE) stake by 83% in Q1 2026, selling an estimated $8.14K and leaving 4 shares worth $1.51K. The position accounts for ﹤0.01% of the portfolio, ranked #1378.

Fortitude Family Office first reported a position in CHE in Q3 2024 and has held it in 7 quarters since. The position peaked at $9.84K in Q4 2025. 488 funds tracked by Wall St. Rank hold CHE as of Q1 2026.

  • Fortitude Family Office held 4 shares of Chemed worth $1.51K as of Q1 2026.
  • Fortitude Family Office sold 19 Chemed shares in Q1 2026, an estimated $8.14K.
  • Chemed made up ﹤0.01% of Fortitude Family Office's portfolio in Q1 2026, its #1378 holding.
  • Fortitude Family Office first reported a position in Chemed in Q3 2024 and has held it in 7 quarters since.
  • Fortitude Family Office's Chemed position peaked at $9.84K in Q4 2025.
  • 488 funds tracked by Wall St. Rank held Chemed as of Q1 2026.

Based on Fortitude Family Office's 13F filing for Q1 2026, filed 16 Apr 2026.